Radio Advisory

More and more employees are rejecting hustle culture and embracing a workplace attitude called “quiet quitting” in which they meet the minimum requirements of their job. In this episode, Rachel (Rae Woods) talks with Joe Folkman, co-founder and President of the leadership and organizational development firm Zenger Folkman, about why he thinks quiet quitting is more of a reflection on leadership and not employees. Rae also talks with Advisory Board researchers Rachel Zuckerman and Allyson Paiewonsky about what quiet quitting could look like in clinical and non-clinical settings. Links: Are your workers 'quiet quitting'? Are your staff 'quiet quitting?' You need to build a better relationship with them. 'Quiet quitting' is happening in healthcare too As we emerge from the global pandemic, healthcare is restructuring. What decisions should you be making, and what do you need to know to make them? Explore the state of the healthcare industry and its outlook for next year by visiting advisory.com/HealthCare2023.

For decades Alzheimer's research was centered around one theory, the amyloid-beta hypothesis. That theory is now being called into question after evidence of potential fraud. In this episode, Rachel (Rae) woods invites life sciences expert Nick Hula and senior care expert Miriam Sznycer-Taub to talk about what this means for the scientific and medical community, how to restore trust in medical research, and where the industry may look to next when it comes to memory care. Links: Is a key Alzheimer's theory based on manipulated research? Ep. 90: Aaron Carroll on how clinicians can combat medical misinformation As we emerge from the global pandemic, healthcare is restructuring. What decisions should you be making, and what do you need to know to make them? Explore the state of the healthcare industry and its outlook for next year by visiting advisory.com/HealthCare2023.

One of the biggest challenges healthcare leaders are grappling with is the workforce shortage, particularly in nursing. This isn’t a new problem, so why haven't we found real solutions? Host Rachel (Rae) Woods invites Henry Ford Health System's Vice President and Chief Innovation Officer Lisa Prasad and Senior Vice President and Chief Nursing Officer Eric Wallis to discuss why we need to look at the nursing shortage as a supply chain issue and what can be done both in short-term and long-term. Links: US workforce could be short 2.1 million nurses by 2025 Why 67% of nurses want to quit—and what would make them stay Our Clinical Workforce playlist Get the Daily Briefing newsletter in your inbox. Subscribe now.

Celebrity entrepreneur Mark Cuban wants to make buying drugs less complicated and more affordable, and an online pharmacy he recently invested in aims to do just that. So how does this work, and is it enough to solve the drug pricing problem in America? Host Rachel (Rae) Woods talks with pharmacy experts Gina Lohr and Chloe Bakst about this business model and drug pricing reforms in the recently passed Inflation Reduction Act. Links: Can Mark Cuban lower Medicare drug costs? A deeper dive into the headlines Could cost plus drug pricing save Medicare billions? Ep. 131: Healthcare disruptors: Why Walgreens wants to partner—not compete Get the Daily Briefing newsletter in your inbox. Subscribe now.

Radio Advisory is rounding out its healthcare disruptor series with an episode about possibly the biggest disruptor of all – Amazon. Their acquisition of One Medical is among the biggest investments in care delivery by a non-healthcare entity. The acquisition has kicked off an arms race for physicians, with organizations like CVS announcing their own massive deals. In this episode, Rachel (Rae) Woods invites digital health experts John League and Ty Aderhold to discuss why Amazon’s investments – and failures – are a catalyst for the rest of the industry (and where they are going next). Links: Amazon is buying One Medical for $3.9B. Here's our take. Who wins: Exploring Amazon’s One Medical acquisition and what it means today (Part 1) 3 scenarios: Exploring Amazon’s One Medical acquisition and what it means for the future of healthcare (Part 2) Amazon Care is shutting down. What's next?

(New/bonus content starts at 22:09. First part of episode originally aired November 2, 2021.) There's been plenty of talk about companies being disruptive in the healthcare industry, from Amazon to Walmart, but a company you might not be thinking about is also making moves into the healthcare world—Best Buy. In this episode, host Rachel Woods sits down with Advisory Board's Miriam Sznycer-Taub to talk about how Best Buy is moving its way into the healthcare world and what that might mean for the healthcare industry. Bonus links: Ep. 131: Healthcare disruptors: Why Walgreens wants to partner—not compete Ep. 130: Healthcare disruptors: Don't discount retailers FDA's new final rule opens up hearing aids to millions of Americans Links: Why you shouldn't rush into home-based care (and what to consider before entering) Home-based care market scan

This episode was recorded on August 5, 2022. In part two of Radio Advisory’s disruptor series, Rachel (Rae) Woods invites Walgreens Health Chief Clinical Officer Dr. Sashi Moodley to discuss the obstacles of being a disruptor in a crowded competitive field, building longitudinal relationships with patients instead of transactional, and Walgreens’s goal of becoming an equal player in the value-based care industry. Links: Ep. 130: Healthcare disruptors: Don't discount retailers Is 'Big Retail' the next big healthcare disruptor? 3 reasons why pharmacy support is critical in an 'everywhere care' world Why the boom in digital pharmacies represents a crossroads for retail pharmacy

It seems like we’re always hearing about new disruptors and competitors aiming to shake up the way healthcare is designed, delivered, and paid for. Perhaps the most notable are the retail disruptors, like Walgreens Health or CVS Health. But how do you know if something is a potential threat that could have a real impact on your business? In this episode, Rachel (Rae) Woods invites healthcare strategy and planning experts Colin Gelbaugh and Gina Lohr to discuss retail disruptors and growing competition in the healthcare industry, and what leaders should be looking for in the future. Links: Is 'Big Retail' the next big healthcare disruptor? 3 reasons why pharmacy support is critical in an 'everywhere care' world Why the boom in digital pharmacies represents a crossroads for retail pharmacy

Buzzwords and phrases like “equity”, “digital divide”, and “cultural competency” are used often health care. However, there’s no real consensus on their actual definitions, and that can be problematic. In this episode, host Rachel (Rae) Woods talks with value-based care expert Daniel Kuzmanovich and health equity researcher Darby Sullivan to discuss why language has never been more important in the industry, and how to ensure that your vocabulary aligns with your organization’s intentions. Links: Is the language we use hurting our equity efforts? It's hard to move VBC forward when nobody understands what you mean Why we hate the phrase 'win-win partnership' in value-based care

During the peak of the pandemic an estimated 9.4 million cancer screenings were missed – which we know led to delayed cancer diagnoses. In this episode, Rachel (Rae) Woods invites oncology experts Ashley Riley and Lauren Woodrow to discuss both the human and system-wide impacts of delayed cancer screenings and what health leaders can do to rebound. Links: Early data shows a rise in advanced cancer diagnoses. But it may not tell the whole story.